120 related articles for article (PubMed ID: 15208626)
21. Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age.
Renes JS; van Doorn J; Hokken-Koelega ACS
Horm Res Paediatr; 2019; 92(1):15-27. PubMed ID: 31509834
[TBL] [Abstract][Full Text] [Related]
22. Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.
Pontes J; Madeira M; Lima CHA; Ogino LL; de Paula Paranhos Neto F; de Mendonça LMC; Farias MLF; Kasuki L; Gadelha MR
J Endocrinol Invest; 2020 Feb; 43(2):163-171. PubMed ID: 31392573
[TBL] [Abstract][Full Text] [Related]
23. The role of BMP6 in the proliferation and differentiation of chicken cartilage cells.
Ye F; Xu H; Yin H; Zhao X; Li D; Zhu Q; Wang Y
PLoS One; 2019; 14(7):e0204384. PubMed ID: 31260450
[TBL] [Abstract][Full Text] [Related]
24. Expression of the growth hormone receptor isoforms and its correlation with the metabolic profile in morbidly obese subjects.
Espinosa E; Salame L; Marrero-Rodriguez D; Romero-Nieves AM; Cuenca D; Castelan-Martínez OD; Mendoza V; Ponce-Navarrete G; Salcedo M; Luque-Leòn E; Rodriguez-Gonzalez A; Mercado M
Endocrine; 2019 Mar; 63(3):573-581. PubMed ID: 30361972
[TBL] [Abstract][Full Text] [Related]
25. Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks.
Díez JJ; Sangiao-Alvarellos S; Cordido F
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562611
[TBL] [Abstract][Full Text] [Related]
26. A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest.
Hartin SN; Hossain WA; Manzardo AM; Brown S; Fite PJ; Bortolato M; Butler MG
Growth Horm IGF Res; 2018 Aug; 41():48-53. PubMed ID: 29459141
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone receptor (GHR) gene polymorphism and scoliosis in Prader-Willi syndrome.
Butler MG; Hossain W; Hassan M; Manzardo AM
Growth Horm IGF Res; 2018 Apr; 39():29-33. PubMed ID: 29273483
[TBL] [Abstract][Full Text] [Related]
28. The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature.
Ben-Avraham D; Govindaraju DR; Budagov T; Fradin D; Durda P; Liu B; Ott S; Gutman D; Sharvit L; Kaplan R; Bougnères P; Reiner A; Shuldiner AR; Cohen P; Barzilai N; Atzmon G
Sci Adv; 2017 Jun; 3(6):e1602025. PubMed ID: 28630896
[TBL] [Abstract][Full Text] [Related]
29. The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis.
Franck SE; Broer L; van der Lely AJ; Kamenicky P; Bernabéu I; Malchiodi E; Delhanty PJD; Rivadeneira F; Neggers SJCMM
Neuroendocrinology; 2017; 105(2):131-140. PubMed ID: 27513761
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone receptor exon 3 isoforms may have no importance in the clinical setting of multiethnic Brazilian acromegaly patients.
de Oliveira Machado E; Lima CH; Ogino LL; Kasuki L; Gadelha MR
Pituitary; 2016 Aug; 19(4):375-80. PubMed ID: 27001494
[TBL] [Abstract][Full Text] [Related]
31. Genetic Variant in ACVR2B Is Associated with Lean Mass.
Klimentidis YC; Bea JW; Thompson P; Klimecki WT; Hu C; Wu G; Nicholas JS; Ryckman KK; Chen Z
Med Sci Sports Exerc; 2016 Jul; 48(7):1270-5. PubMed ID: 26848890
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and natural course of acromegaly in patients with discordance in the nadir GH level on the oral glucose test and the IGF-1 value at 3 months after adenomectomy.
Kinoshita Y; Tominaga A; Usui S; Arita K; Sakoguchi T; Sugiyama K; Kurisu K
Neurosurg Rev; 2016 Apr; 39(2):313-8; discussion 318-9. PubMed ID: 26785642
[TBL] [Abstract][Full Text] [Related]
33. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
[TBL] [Abstract][Full Text] [Related]
34. Exon 3-deleted and full-length growth hormone receptor polymorphism frequencies in an Iranian population.
Palizban AA; Radmansorry M; Bozorgzad M
Res Pharm Sci; 2014; 9(6):489-94. PubMed ID: 26339263
[TBL] [Abstract][Full Text] [Related]
35. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
Wei Y; Zheng R; Zhou Y; Wang J; Bao P
Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
[TBL] [Abstract][Full Text] [Related]
36. Relationship between initial treatment effect of recombinant human growth hormone and exon 3 polymorphism of growth hormone receptor in Chinese children with growth hormone deficiency.
Zheng Z; Cao L; Pei Z; Zhi D; Zhao Z; Xi L; Cheng R; Luo F
Int J Clin Exp Med; 2015; 8(5):7965-70. PubMed ID: 26221355
[TBL] [Abstract][Full Text] [Related]
37. Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples.
Pelekanos RA; Sardesai VS; Dekker Nitert M; Callaway LK; Fisk NM; Jeffery PL
Endocrine; 2015 Aug; 49(3):643-52. PubMed ID: 26067082
[TBL] [Abstract][Full Text] [Related]
38. The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.
Ouni M; Belot MP; Castell AL; Fradin D; Bougnères P
Pharmacogenomics J; 2016 Feb; 16(1):102-6. PubMed ID: 25869012
[TBL] [Abstract][Full Text] [Related]
39. Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.
Ouni M; Castell AL; Linglart A; Bougnères P
J Clin Endocrinol Metab; 2015 Jun; 100(6):E919-25. PubMed ID: 25835289
[TBL] [Abstract][Full Text] [Related]
40. The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.
Ouni M; Gunes Y; Belot MP; Castell AL; Fradin D; Bougnères P
Clin Epigenetics; 2015; 7(1):22. PubMed ID: 25789079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
